Anticoagulation in COVID-19: It Is Time for High-Quality Evidence.
Publication
, Journal Article
Lopes, RD; Fanaroff, AC
Published in: J Am Coll Cardiol
October 20, 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Am Coll Cardiol
DOI
EISSN
1558-3597
Publication Date
October 20, 2020
Volume
76
Issue
16
Start / End Page
1827 / 1829
Location
United States
Related Subject Headings
- SARS-CoV-2
- Pneumonia, Viral
- Pandemics
- Humans
- Hemorrhage
- Coronavirus Infections
- Cardiovascular System & Hematology
- COVID-19
- Betacoronavirus
- Anticoagulants
Citation
APA
Chicago
ICMJE
MLA
NLM
Lopes, R. D., & Fanaroff, A. C. (2020). Anticoagulation in COVID-19: It Is Time for High-Quality Evidence. J Am Coll Cardiol, 76(16), 1827–1829. https://doi.org/10.1016/j.jacc.2020.09.008
Lopes, Renato D., and Alexander C. Fanaroff. “Anticoagulation in COVID-19: It Is Time for High-Quality Evidence.” J Am Coll Cardiol 76, no. 16 (October 20, 2020): 1827–29. https://doi.org/10.1016/j.jacc.2020.09.008.
Lopes RD, Fanaroff AC. Anticoagulation in COVID-19: It Is Time for High-Quality Evidence. J Am Coll Cardiol. 2020 Oct 20;76(16):1827–9.
Lopes, Renato D., and Alexander C. Fanaroff. “Anticoagulation in COVID-19: It Is Time for High-Quality Evidence.” J Am Coll Cardiol, vol. 76, no. 16, Oct. 2020, pp. 1827–29. Pubmed, doi:10.1016/j.jacc.2020.09.008.
Lopes RD, Fanaroff AC. Anticoagulation in COVID-19: It Is Time for High-Quality Evidence. J Am Coll Cardiol. 2020 Oct 20;76(16):1827–1829.
Published In
J Am Coll Cardiol
DOI
EISSN
1558-3597
Publication Date
October 20, 2020
Volume
76
Issue
16
Start / End Page
1827 / 1829
Location
United States
Related Subject Headings
- SARS-CoV-2
- Pneumonia, Viral
- Pandemics
- Humans
- Hemorrhage
- Coronavirus Infections
- Cardiovascular System & Hematology
- COVID-19
- Betacoronavirus
- Anticoagulants